Epilepsy affects more than 50 million people worldwide, making it one of the most common neurological disorders. Although medication helps many patients achieve seizure control, approximately ...
Epilepsy affects over 50 million people worldwide, making it one of the most common neurological disorders. Although ...
Led by the venture arm of a strategic partner, proceeds will support inventory build and commercialization of proprietary polyclonal stem cells engineered with safety and universality features to ...
The introduction of chimeric antigen receptor (CAR) T-cell therapies marked a major advance in treating B-cell lymphomas and leukemias. Almost 10 years have passed since the first CAR T-cell therapy ...
Good day, ladies and gentlemen, and welcome to the Repligen Corporation Acquisition of BioLife Solutions Conference Call. My name is Elizabeth, and I will be your coordinator. [Operator Instructions] ...
Good day, everyone, and welcome to today's conference call to discuss the 12-month results from our ongoing open-label extension study of TPIP in patients with PAH. Before we start, please note that ...
Spread the love“`html The quest to reverse aging has long captivated scientists and laypeople alike. For decades, the dream ...
Abstract: Cancer comprises diverse subtypes with distinct clinical implications, making accurate classification essential for prognosis and prediction. Single-omics data are insufficient due to gene ...
Spread the love“`html Why Millions Are Ditching Antidepressants For Gut Health: The Game-Changing 2026 Breakthroughs Why ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results